CELH now trades at 28X forward earnings with revenues expected to grow 15% this coming year and EPS to grow at 35%. Sentiment and momentum has not been great to say the least but the long-term growth opportunity remains and they continue to outperform peers in the sector, which is seeing a slowdown across the board. CELH is technically staples, but for a replacement with growth in the discretionary space, ATZ might be worth considering.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in CELH.